Screener
Alvotech
ALVOAlvotech is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Lisa Graver, with a market cap of $1.3B.
$1.28B-51.6%
We’re still putting together Alvotech’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Alvotech up the queue, and we’ll analyze its filings next.
Earnings
Next report
Aug 19, 2026 (In 2 weeks)Revenue estimate$103.0M
EPS estimate-$0.05
Profile
CountryIceland
Listed2022
Employees999.0
CEOLisa Graver
SectorHealthcare
Websitealvotech.com
FilingsSEC EDGAR